{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1892553967973121024.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"BindingDB"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1882553967973121024","@type":"Dataset","productIdentifier":[{"@type":"DOI","@value":"10.7270/q2ff3v2h"}],"notation":[{"@value":"BindingDB Entry 50045645: Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity."}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"OPENAIRE","@value":"doi_________::fd5c2726aaed21a0a3ab68172f890a17_YFtHsQPs2QwTg4a7CC7HbZIINAP"}]}